Integrated approaches for the recognition of small molecule inhibitors for Toll-like receptor 4

Toll-like receptors (TLRs) are pattern recognition receptors present on the surface of cells playing a crucial role in innate immunity. One of the TLRs, TLR4, recognizes LPS (Lipopolysaccharide) as its ligand leading to the release of anti-inflammatory mediators as well as pro-inflammatory cytokines...

Full description

Bibliographic Details
Main Authors: Shailya Verma, Purushotham Reddy, R. Sowdhamini
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:Computational and Structural Biotechnology Journal
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2001037023002556
_version_ 1827577643235540992
author Shailya Verma
Purushotham Reddy
R. Sowdhamini
author_facet Shailya Verma
Purushotham Reddy
R. Sowdhamini
author_sort Shailya Verma
collection DOAJ
description Toll-like receptors (TLRs) are pattern recognition receptors present on the surface of cells playing a crucial role in innate immunity. One of the TLRs, TLR4, recognizes LPS (Lipopolysaccharide) as its ligand leading to the release of anti-inflammatory mediators as well as pro-inflammatory cytokines through signal transduction and domain recruitment. TLR4 homodimerizes at its intracellular TIR (Toll/interleukin-1 receptor) domain that helps in the recruitment of the TRAM/TICAM2 (TIR domain-containing adaptor molecule 2) molecule. TRAM also contains TIR domain which in turn, dimerizes and functions as an adapter protein to further recruit TRIF/TICAM1 (TIR domain-containing adaptor molecule 1) protein for mediating downstream signaling. Apart from LPS, TLR4 also recognizes endogenous ligands like fibrinogen, HMGB1, and hyaluronan in autoimmune conditions and sepsis. We employed computational approaches to target TRAM and recognize small molecule inhibitors from small molecules of natural origin, as contained in the Super Natural II database. Finally, cell reporter assays and NMR studies enabled the identification of promising lead compounds. Hence, this study aims to attenuate the signaling of the TLR4-TRAM-TRIF cascade in these auto-inflammatory conditions.
first_indexed 2024-03-08T21:30:44Z
format Article
id doaj.art-fb02d01ad0924b98a9735dba8fd0f447
institution Directory Open Access Journal
issn 2001-0370
language English
last_indexed 2024-03-08T21:30:44Z
publishDate 2023-01-01
publisher Elsevier
record_format Article
series Computational and Structural Biotechnology Journal
spelling doaj.art-fb02d01ad0924b98a9735dba8fd0f4472023-12-21T07:31:49ZengElsevierComputational and Structural Biotechnology Journal2001-03702023-01-012136803689Integrated approaches for the recognition of small molecule inhibitors for Toll-like receptor 4Shailya Verma0Purushotham Reddy1R. Sowdhamini2National Centre for Biological Sciences (TIFR), GKVK campus, Bangalore 560065, IndiaNational Centre for Biological Sciences (TIFR), GKVK campus, Bangalore 560065, India; NMR-Analytical research and development, Aurobindo Pharma, Research center-II, Hyderabad, Telangana 502307, IndiaNational Centre for Biological Sciences (TIFR), GKVK campus, Bangalore 560065, India; Molecular Biophysics Unit, Indian Institute of Science, Bangalore 560012, India; Institute of Bioinformatics and Applied Biotechnology, Electronic City, 560100, India; Corresponding author at: National Centre for Biological Sciences (TIFR), GKVK campus, Bangalore, 560065, India.Toll-like receptors (TLRs) are pattern recognition receptors present on the surface of cells playing a crucial role in innate immunity. One of the TLRs, TLR4, recognizes LPS (Lipopolysaccharide) as its ligand leading to the release of anti-inflammatory mediators as well as pro-inflammatory cytokines through signal transduction and domain recruitment. TLR4 homodimerizes at its intracellular TIR (Toll/interleukin-1 receptor) domain that helps in the recruitment of the TRAM/TICAM2 (TIR domain-containing adaptor molecule 2) molecule. TRAM also contains TIR domain which in turn, dimerizes and functions as an adapter protein to further recruit TRIF/TICAM1 (TIR domain-containing adaptor molecule 1) protein for mediating downstream signaling. Apart from LPS, TLR4 also recognizes endogenous ligands like fibrinogen, HMGB1, and hyaluronan in autoimmune conditions and sepsis. We employed computational approaches to target TRAM and recognize small molecule inhibitors from small molecules of natural origin, as contained in the Super Natural II database. Finally, cell reporter assays and NMR studies enabled the identification of promising lead compounds. Hence, this study aims to attenuate the signaling of the TLR4-TRAM-TRIF cascade in these auto-inflammatory conditions.http://www.sciencedirect.com/science/article/pii/S2001037023002556Toll-like receptorTIR domainAutoimmuneVirtual screeningMD simulationsReporter assay
spellingShingle Shailya Verma
Purushotham Reddy
R. Sowdhamini
Integrated approaches for the recognition of small molecule inhibitors for Toll-like receptor 4
Computational and Structural Biotechnology Journal
Toll-like receptor
TIR domain
Autoimmune
Virtual screening
MD simulations
Reporter assay
title Integrated approaches for the recognition of small molecule inhibitors for Toll-like receptor 4
title_full Integrated approaches for the recognition of small molecule inhibitors for Toll-like receptor 4
title_fullStr Integrated approaches for the recognition of small molecule inhibitors for Toll-like receptor 4
title_full_unstemmed Integrated approaches for the recognition of small molecule inhibitors for Toll-like receptor 4
title_short Integrated approaches for the recognition of small molecule inhibitors for Toll-like receptor 4
title_sort integrated approaches for the recognition of small molecule inhibitors for toll like receptor 4
topic Toll-like receptor
TIR domain
Autoimmune
Virtual screening
MD simulations
Reporter assay
url http://www.sciencedirect.com/science/article/pii/S2001037023002556
work_keys_str_mv AT shailyaverma integratedapproachesfortherecognitionofsmallmoleculeinhibitorsfortolllikereceptor4
AT purushothamreddy integratedapproachesfortherecognitionofsmallmoleculeinhibitorsfortolllikereceptor4
AT rsowdhamini integratedapproachesfortherecognitionofsmallmoleculeinhibitorsfortolllikereceptor4